195 related articles for article (PubMed ID: 31426735)
1. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2017.
Bell JM; Gottlieb T; Daley DA; Coombs GW
Commun Dis Intell (2018); 2019 Aug; 43():. PubMed ID: 31426735
[TBL] [Abstract][Full Text] [Related]
2. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2018.
Bell JM; Gottlieb T; Daley DA; Coombs GW
Commun Dis Intell (2018); 2020 Oct; 44():. PubMed ID: 33081651
[TBL] [Abstract][Full Text] [Related]
3. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2019.
Bell JM; Lubian AF; Partridge S; Gottlieb T; Iredell J; Daley DA; Coombs GA
Commun Dis Intell (2018); 2020 Oct; 44():. PubMed ID: 33081652
[TBL] [Abstract][Full Text] [Related]
4. Australian Group on Antimicrobial Resistance Australian Enterobacteriaceae Sepsis Outcome Programme annual report, 2014.
Bell JM; Turnidge JD; Coombs GW; Daley DA; Gottlieb T; Robson J; George N
Commun Dis Intell Q Rep; 2016 Jun; 40(2):E229-35. PubMed ID: 27522134
[TBL] [Abstract][Full Text] [Related]
5. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GnSOP) Annual Report 2020.
Bell JM; Lubian AF; Partridge SR; Gottlieb T; Iredell J; Daley DA; Coombs GW
Commun Dis Intell (2018); 2022 Mar; 46():. PubMed ID: 35382709
[TBL] [Abstract][Full Text] [Related]
6. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2022.
Bell JM; Fajardo Lubian A; Partridge SR; Gottlieb T; Robson J; Iredell JR; Daley DA; Coombs GW
Commun Dis Intell (2018); 2023 Nov; 47():. PubMed ID: 37968067
[TBL] [Abstract][Full Text] [Related]
7. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2016.
Bell JM; Gottlieb T; Daley DA; Coombs GW
Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30626303
[TBL] [Abstract][Full Text] [Related]
8. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme(GNSOP) Annual Report 2015.
Bell JM; Gottlieb T; Daley DA; Coombs GW;
Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30632360
[TBL] [Abstract][Full Text] [Related]
9. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.
Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E327-33. PubMed ID: 25631595
[TBL] [Abstract][Full Text] [Related]
10. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP).
Bell JM; Lubian AF; Partridge SR; Gottlieb T; Robson J; Iredell JR; Daley DA; Coombs GW
Commun Dis Intell (2018); 2022 Nov; 46():. PubMed ID: 36384435
[TBL] [Abstract][Full Text] [Related]
11. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2015.
Coombs GW; Daley DA; Lee YT; Pang S; Bell JM; Turnidge JD;
Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30632361
[TBL] [Abstract][Full Text] [Related]
12. Hospital-onset Gram-negative Surveillance Program annual report, 2011.
Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Pearson JC; Bell JM;
Commun Dis Intell Q Rep; 2014 Mar; 38(1):E49-53. PubMed ID: 25409355
[TBL] [Abstract][Full Text] [Related]
13. Australian Group on Antimicrobial Resistance Community-onset Gram-negative Surveillance Program annual report, 2010.
Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Pearson JC; Bell JM;
Commun Dis Intell Q Rep; 2013 Sep; 37(3):E219-23. PubMed ID: 24890957
[TBL] [Abstract][Full Text] [Related]
14. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
15. Community-onset Gram-negative Surveillance Program annual report, 2012.
Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
Commun Dis Intell Q Rep; 2014 Mar; 38(1):E54-8. PubMed ID: 25409356
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance in gram-negative bacilli: a Singapore perspective.
Tan TY; Hsu LY; Koh TH; Ng LS; Tee NW; Krishnan P; Lin RT; Jureen R
Ann Acad Med Singap; 2008 Oct; 37(10):819-25. PubMed ID: 19037514
[TBL] [Abstract][Full Text] [Related]
17. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
Zarakolu P; Hasçelik G; Unal S
Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).
Cantón R; Loza E; Aznar J; Calvo J; Cercenado E; Cisterna R; Romo FG; Hontangas JL; Calvo CR; Barrenechea AI; Tubau F; Weber I; Yuste P; Cavanillas R;
Rev Esp Quimioter; 2011 Dec; 24(4):223-32. PubMed ID: 22173194
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.
Jones RN; Pfaller MA; Marshall SA; Hollis RJ; Wilke WW
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):187-92. PubMed ID: 9401811
[TBL] [Abstract][Full Text] [Related]
20. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
Pfaller MA; Shortridge D; Sader HS; Castanheira M; Flamm RK
Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
